HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 94 filers reported holding HARVARD BIOSCIENCE INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $28,000 | -40.4% | 12,700 | -18.1% | 0.01% | -22.2% |
| Q4 2019 | $47,000 | -2.1% | 15,500 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $48,000 | +54.8% | 15,500 | 0.0% | 0.02% | +50.0% |
| Q2 2019 | $31,000 | -53.7% | 15,500 | 0.0% | 0.01% | -52.0% |
| Q1 2019 | $67,000 | +36.7% | 15,500 | 0.0% | 0.02% | +25.0% |
| Q4 2018 | $49,000 | -48.4% | 15,500 | -14.4% | 0.02% | -41.2% |
| Q3 2018 | $95,000 | -2.1% | 18,100 | 0.0% | 0.03% | -2.9% |
| Q2 2018 | $97,000 | -31.2% | 18,100 | -35.8% | 0.04% | -32.7% |
| Q1 2018 | $141,000 | +51.6% | 28,200 | 0.0% | 0.05% | +52.9% |
| Q4 2017 | $93,000 | -12.3% | 28,200 | 0.0% | 0.03% | – |
| Q3 2017 | $106,000 | +47.2% | 28,200 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $72,000 | -1.4% | 28,200 | 0.0% | 0.03% | -6.7% |
| Q1 2017 | $73,000 | – | 28,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |